New iOS App Connects Patients to Doctors and Specialists On-Demand

Santa Ana, CA -- (SBWIRE) -- 07/26/2017 -- A simple yet revolutionary new telemedicine application, OmniaMD, launched today and is officially seeing patients and recruiting board-certified physicians in California. Created by Newport Beach Cardiologist and Harvard Medical School graduate Dr. Jorge Castellanos and former Cedars-Sinai RN Lauren Timpe, OmniaMD connects doctors and patients through iOS-based video calls on-demand for a flat rate of $59—no insurance needed.

OmniaMD uses a proprietary, encrypted connection in order for its board-certified physician team to securely connect with a patient. The patient pays a flat fee of $59 per video call, and insurance is not currently needed nor accepted. OmniaMD physicians assess the condition of the patient based on a visual and verbal consultation and provide medical advice or a prescription.

"Seeing a doctor is not as easy as it should be. We built OmniaMD to break down the barriers between doctor and patient, and allow them to connect face-to-face at any time. OmniaMD enriches the doctor-patient relationship, and gets the people the help they need right when they need it," said Dr. Jorge Castellanos, co-founder of OmniaMD.

OmniaMD also allows patients to select their physician based on specialty. OmniaMD physicians treat a variety of areas of medicine without being physically present, from cardiology to internal medicine.

OmniaMD has a core group of current providers, but is currently recruiting board-certified physicians in California for its founding class. OmniaMD physicians can work anytime and anywhere, and founding class members make $40 per call. There is no cost for physicians to join OmniaMD and medical malpractice coverage is included.

In order to learn more about OmniaMD, please visit our website. Download OmniaMD for iOS now.

In order to apply to become an OmniaMD physician, please visit https://omniamd.com/registration/.

For more information on this press release visit: http://www.releasewire.com/press-releases/release-3.htm